X
Please Wait
Applying Filters...
01 SANOFI AVENTIS US (3)
01 TABLET;ORAL (3)
01 RX (3)
01 AVAPRO (3)
01 Yes (3)
78th STLE Annual Meeting
Not Confirmed
Contact Supplier78th STLE Annual Meeting
Not Confirmed
Contact Supplier78th STLE Annual Meeting
Not Confirmed
Contact Supplier19
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is IRBESARTAN, with a corresponding application number 20757.
Regulatory Information RX
With a dosage strength 150MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1997-09-30
Therapeutic Equivalence (TE) Code AB
18
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is IRBESARTAN, with a corresponding application number 20757.
Regulatory Information RX
With a dosage strength 300MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1997-09-30
Therapeutic Equivalence (TE) Code AB
17
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is IRBESARTAN, with a corresponding application number 20757.
Regulatory Information RX
With a dosage strength 75MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1997-09-30
Therapeutic Equivalence (TE) Code AB
Market Place
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
